| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.006 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |